Moore Kuehn Encourages RST, AKCA, DCOM, and SBPH Investors to Contact Law Firm

NEW YORK, Sept. 22, 2020

• Rosetta Stone Inc. (NYSE: RST)

A solicitation statement was recently filed with the SEC regarding Cambium Learning Group's acquisition of Rosetta Stone, which may omit material information regarding the financial metrics and analyses used to evaluate the merger.  Under the proposed transaction, shareholders of Rosetta Stone will receive $30.00 for every share owned.

• Akcea Therapeutics, Inc. (NASDAQ: AKCA)

Akcea has agreed to be acquired by Ionis.  Under the proposed transaction, shareholders of Akcea will receive $18.15 for each share owned.

• Dime Community Bancshares, Inc. (NASDAQ: DCOM)

A registration statement was recently filed with the SEC regarding Bridge Bancorp's acquisition of Dime.  Upon completion of the merger, shareholders of Dime will receive 0.6480 shares of Bridge Bancorp for every share owned.  The investigation concerns whether Dime's board of directors oversaw an unfair process and ultimately agreed to an inadequate deal price.

• Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH)

A registration statement was recently filed with the SEC regarding F-star Therapeutics' acquisition of Spring Bank.  Upon completion of the merger, shareholders of Spring Bank will only own approximately 38.8% of the combined company. 

Moore Kuehn is investigating whether the Boards of the above companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process.